Stryker Corporation $SYK Shares Bought by Manitou Investment Management Ltd.

Manitou Investment Management Ltd. lifted its position in Stryker Corporation (NYSE:SYK) by 40.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 117,276 shares of the medical technology company’s stock after buying an additional 33,812 shares during the quarter. Stryker comprises approximately 6.9% of Manitou Investment Management Ltd.’s holdings, making the stock its 6th biggest position. Manitou Investment Management Ltd.’s holdings in Stryker were worth $36,923,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Sankala Group LLC bought a new position in shares of Stryker during the 4th quarter worth approximately $26,000. Godfrey Financial Associates Inc. acquired a new stake in Stryker during the 4th quarter valued at $26,000. United Financial Planning Group LLC bought a new stake in shares of Stryker during the 3rd quarter worth about $27,000. Atlas Capital Advisors Inc. bought a new position in Stryker in the 4th quarter valued at about $27,000. Finally, DJE Kapital AG acquired a new stake in Stryker during the fourth quarter worth approximately $28,000. Institutional investors own 77.09% of the company’s stock.

Insider Buying and Selling

In related news, Director Ronda E. Stryker sold 310,000 shares of the company’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $312.23, for a total transaction of $96,791,300.00. Following the completion of the sale, the director directly owned 1,924,880 shares in the company, valued at $601,005,282.40. This represents a 13.87% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, VP Robert S. Fletcher sold 4,544 shares of Stryker stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $306.87, for a total transaction of $1,394,417.28. Following the sale, the vice president directly owned 10,582 shares in the company, valued at $3,247,298.34. This trade represents a 30.04% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 323,264 shares of company stock worth $100,659,489 in the last ninety days. 4.60% of the stock is owned by insiders.

Stryker Trading Down 0.0%

Shares of NYSE:SYK opened at $336.91 on Friday. The business’s 50 day simple moving average is $319.45 and its 200 day simple moving average is $334.10. Stryker Corporation has a 1 year low of $281.00 and a 1 year high of $396.86. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.16 and a quick ratio of 1.33. The company has a market capitalization of $129.23 billion, a P/E ratio of 34.91, a P/E/G ratio of 2.15 and a beta of 0.76.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Thursday, July 30th. The medical technology company reported $3.69 earnings per share for the quarter, beating the consensus estimate of $3.49 by $0.20. The firm had revenue of $6.59 billion during the quarter, compared to analysts’ expectations of $6.58 billion. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The company’s quarterly revenue was up 9.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.13 EPS. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. On average, research analysts anticipate that Stryker Corporation will post 15.02 EPS for the current fiscal year.

Stryker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be given a dividend of $0.88 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.52 annualized dividend and a dividend yield of 1.0%. Stryker’s dividend payout ratio (DPR) is currently 36.48%.

Analyst Ratings Changes

Several equities analysts have recently commented on SYK shares. Wall Street Zen downgraded Stryker from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. Barclays reduced their price target on Stryker from $469.00 to $394.00 and set an “overweight” rating for the company in a research note on Monday, May 4th. The Goldman Sachs Group reaffirmed a “neutral” rating and issued a $361.00 price objective on shares of Stryker in a report on Friday, May 1st. Needham & Company LLC lowered their price objective on Stryker from $454.00 to $418.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Finally, Raymond James Financial set a $370.00 target price on shares of Stryker in a research report on Friday, July 31st. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $386.28.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.